Page 1

Nanobodies Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

© Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Nanobodies Market – Overview Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. These technology was developed from antigen binding fragments, originating from Camelid heavychain antibodies. These molecules do not have light chains, which is an essential part of antibody found in humans. Based on the above finding, nanobodies molecule containing single-domain only were developed, and these molecules contain functional and structural properties similar to heavy chain antibodies. These molecules have several advantages as compared to the conventional antibodies such as small-size, nano to picomolar affinities, and multiple route of administration. Ablynx, which is acquired by Sanofi S.A., is one of the leading company in this market. Currently, no products are available in the market, but there are multiple products in the pipeline including few in very late stage of clinical trials. For instance, marketing authorization application for Caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) has been submitted to European Medicine Agency (EMA) in February 2017. The product, Caplacizumab, is expected to be launched in Europe in 2018. Moreover, the company, Ablynx, is expected to file for biologic license agreement to the U.S. Food and Drug Administration (FDA) in 2018, and is expected to launch this product in U.S. in 2019. Both, Europe and U.S. are the key markets for any biologics including monoclonal antibodies and are expected to be the high revenue generating market for nanobodies.

Š Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Nanobodies Market Taxonomy: By Product Type: ●

Mono-specific

Monovalent

Multivalent

Bi-paratopic

Multi-specific

By Indication: ●

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Respiratory Syncytial Virus (RSV) Infection

Rheumatoid Arthritis

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1680 © Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Nanobodies Market: Key Players ●

Ablynx (now part of Sanofi S. A.

Novo Nordisk A/S,

Merck & Co., Inc.,

Merck KGaA,

AbbVie, Inc., and

C.H. Boehringer Sohn AG & Ko. KG.

View this report @ https://www.coherentmarketinsights.com/ongoing-insight/nanobodies-market-1680 © Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL IMAGING

PHARMACEUTICAL

MEDICAL DEVICES

Chemicals & Materials

Bulk Chemicals

Advanced

Materials

Speciality and Fine Chemicals

Green Chemicals Food Ingredients

© Coherent market Insights. All Rights Reserved

Cosmetic Ingredients

Polymers & Resins


ABOUT COHERENT MARKET INSIGHTS KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+

Insights Published Per Year

150+

Consulting Projects Till Date

125+

Clients Worldwide Per Year

110+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEARC H

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved


To know more about us, visit our website: www.coherentmarketinsights.com

THANK YOU

Š Coherent market Insights. All Rights Reserved

For sales queries or new topics emailus on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Nanobodies Market - Global Industry Insights, Trends, Outlook, and Analysis, 2018-2026  

Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research.

Nanobodies Market - Global Industry Insights, Trends, Outlook, and Analysis, 2018-2026  

Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research.

Advertisement